CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
B-NHL · B-Non Hodgkin Lymphoma · Acute Lymphocytic Leukemia · Acute Lymphoblastic Leukemia · B-precursor ALL · B-All · Lymphoma, Non-Hodgkin · Leukemia, Lymphocytic, B Cell · B-Cell Lymphoma · B-Cell Leukemia · Acute Lymphoid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact National Cancer Institute Referral Office) · 888-624-1937
Study leads
Sara K Silbert, M.D.
Principal Investigator
National Cancer Institute (NCI)